Israel Englander’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$623K Sell
6,700
-13,300
-67% -$1.25M ﹤0.01% 4627
2026
Q1
$1.78M Buy
+20,000
New +$2.06M ﹤0.01% 3987
2025
Q3
Sell
-30,400
Closed -$3.24M 6035
2025
Q2
$3.24M Buy
+30,400
New +$3.07M ﹤0.01% 3425
2025
Q1
Sell
-16,700
Closed -$1.9M 5880
2024
Q4
$1.9M Sell
16,700
-5,100
-23% -$582K ﹤0.01% 3687
2024
Q3
$2.59M Sell
21,800
-300
-1% -$27.6K ﹤0.01% 3463
2024
Q2
$1.78M Sell
22,100
-2,800
-11% -$256K ﹤0.01% 3633
2024
Q1
$2.3M Sell
24,900
-36,200
-59% -$3.47M ﹤0.01% 3609
2023
Q4
$6.45M Buy
61,100
+39,300
+180% +$3.96M ﹤0.01% 2573
2023
Q3
$2.37M Buy
21,800
+15,500
+246% +$1.71M ﹤0.01% 3401
2023
Q2
$680K Buy
+6,300
New +$709K ﹤0.01% 4325
2022
Q1
Sell
-68,500
Closed -$17.7M 6918
2021
Q4
$17.7M Buy
68,500
+8,500
+14% +$2.33M 0.01% 1555
2021
Q3
$16.4M Buy
60,000
+35,000
+140% +$11.1M 0.01% 1518
2021
Q2
$5.6M Sell
25,000
-25,000
-50% -$4.71M ﹤0.01% 2607
2021
Q1
$5.46M Hold
50,000
﹤0.01% 2477
2020
Q4
$4.08M Sell
50,000
-10,000
-17% -$982K ﹤0.01% 2645
2020
Q3
$4.15K Buy
+60,000
New +$4.3M 0.01% 2005

Other funds holding BNTX

Israel Englander's BNTX Position: Q2 2026 in Review

Israel Englander sold out of BioNTech (BNTX) in Q2 2026, closing a stake of 35,372 shares — an estimated $3.33M sold.

Israel Englander first reported a position in BNTX in Q4 2019 and held it in 25 quarters. The position peaked at $84.6M in Q3 2021. 281 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Israel Englander reported no remaining BioNTech position as of Q2 2026 after selling out during the quarter.
  • Israel Englander sold 35,372 BioNTech shares in Q2 2026, an estimated $3.33M.
  • Israel Englander first reported a position in BioNTech in Q4 2019 and held it in 25 quarters.
  • Israel Englander's BioNTech position peaked at $84.6M in Q3 2021.
  • 281 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.